Found 213 matching trials
Using ctDNA to Determine Therapies for Lung Cancer
PHASE2This is a study to look at whether the presence of circulating tumour DNA (...
Location
Princess Margaret Cancer Centre
Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer
N/AThis study dynamically monitored the prognosis of stage I-IV colorectal can...
Status
Active Not Recruiting
Location
Cancer hospital Chinese academy of medical sciences
Biomarkers for Risk Stratification in Lung Cancer
N/AThis is a prospective observational study that will follow patients who und...
Location
Zuckerberg San Francisco General Hospital and Trauma Center
Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.
N/ACirculating free cell DNA (cfDNA) is extracellular fragmentation of nucleic...
Location
Stanford Genome Technology Center
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
NACUPCAKE is a randomized, non-comparative, multicenter, proof-of-concept pha...
Location
Sainte-Catherine Institut du Cancer Avignon-Provence
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
N/AEsophageal cancer is a highly aggressive malignancy with poor prognosis, ra...
Location
Cancer hospital, Chinese academy of medical sciences
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.
PHASE2Recently, a number of clinical studies were carried out to evaluate the the...
Location
Multiple Locations
Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma
N/APediatric soft tissue sarcoma is made up of different subtypes, some of whi...
Location
Sun Yat-sen University Cancer Center
Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)
N/AThe goal of this observational study or is to explore the correlation betwe...
Location
Sun Yat-sen University Cancer Center
Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA
PHASE2Treatment efficacy of osimertinib will be assessed in patients with lung ca...
Location
Chonnam National University Hwasun Hospital